Defective Medical Devices
Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.
Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.
In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.
If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Defective Medical Devices
Links on the Web
 MedWatch Safety Alert RSS FeedFDA MedWatch Safety Alerts |
| Wed, 08 Sep 2010 13:50:00 -0400 AngioSculpt "EX" PTCA Scoring Balloon Catheter by AngioScore, Inc.: Recall - Risk of Catheter Separation Fragments of the catheter may become lodged in coronary arteries, resulting in serious injury or death. Click here to read this Defective Medical Devices news article. |
| Wed, 01 Sep 2010 10:00:00 -0400 Tygacil (tigecycline): Label Change - Increased Mortality Risk Healthcare professionals should consider alternatives to Tygacil in patients with severe infections. Click here to read this Defective Medical Devices news article. |
| Thu, 26 Aug 2010 15:40:00 -0400 Huber Needles: Recall - Risk of Coring Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient?s lungs. Click here to read this Defective Medical Devices news article. |
| Thu, 26 Aug 2010 14:30:00 -0400 Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices. Click here to read this Defective Medical Devices news article. |
| Wed, 25 Aug 2010 15:25:00 -0400 TimeOut Capsules: Undeclared Drug Ingredient Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels. Click here to read this Defective Medical Devices news article. |
| Wed, 25 Aug 2010 12:38:00 -0400 MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels. Click here to read this Defective Medical Devices news article. |
| National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH) |
| Thu, 09 Sep 2010 09:21:00 EDT NIH-funded studies aim to prevent, treat childhood obesity The National Institutes of Health is launching two major research efforts, totaling $72.5 million, to examine ways to curtail the nation's childhood obesity epidemic. One will study long-term approaches to prevent or treat childhood obesity, and the other will examine community efforts to reduce childhood obesity rates. Click here to read this Defective Medical Devices news article. |
| Wed, 08 Sep 2010 16:26:00 EDT Funds awarded for disease demonstration studies and technology development The National Institutes of Health today announced it has awarded approximately $42 million to expand the scope of eight demonstration projects designed to link changes in the human microbiome to health and disease. The funds will also support investigators to develop innovative technologies to improve the identification and characterization of microbial communities of the human microbiome. Click here to read this Defective Medical Devices news article. |
| Tue, 07 Sep 2010 16:26:00 EDT Mild cognitive impairment more common in older men than older women Older men may be at risk of developing mild cognitive impairment (MCI), often a precursor to Alzheimer's disease, earlier in life than older women, according to a study appearing today in Neurology. Click here to read this Defective Medical Devices news article. |
| Tue, 07 Sep 2010 12:01:00 EDT NIH study shows how insulin stimulates fat cells to take in glucose Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism. Click here to read this Defective Medical Devices news article. |
| Tue, 07 Sep 2010 11:01:00 EDT NIH to launch Gulf oil spill health study The National Institutes of Health will launch a multi-year study this fall to look at the potential health effects from the oil spill in the Gulf region. The Gulf Worker Study, announced by NIH Director Francis S. Collins, M.D., Ph.D., in June, is in response to the largest oil spill in U.S. history, caused by the explosion of the Deepwater Horizon offshore drilling oil rig in the Gulf of Mexico. Dr. Collins pledged $10 million in NIH funding for the study's initial phases. Click here to read this Defective Medical Devices news article. |
| Tue, 07 Sep 2010 10:46:00 EDT NIH expands key pharmacogenomics resource To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB), http://www.pharmgkb.org/. Click here to read this Defective Medical Devices news article. |
